TY - JOUR
T1 - Sensitive quantitative assays for tau and phospho-tau in transgenic mouse models
AU - Acker, Christopher M.
AU - Forest, Stefanie K.
AU - Zinkowski, Ray
AU - Davies, Peter
AU - d'Abramo, Cristina
N1 - Funding Information:
This work was supported by NIMH38623 and NIH - AG022102 .
PY - 2013/1
Y1 - 2013/1
N2 - Transgenic mouse models have been an invaluable resource in elucidating the complex roles of β-amyloid and tau in Alzheimer's disease. Although many laboratories rely on qualitative or semiquantitative techniques when investigating tau pathology, we have developed 4 Low-Tau, Sandwich enzyme-linked immunosorbent assays (ELISAs) that quantitatively assess different epitopes of tau relevant to Alzheimer's disease: total tau, pSer-202, pThr-231, and pSer-396/404. In this study, after comparing our assays with commercially available ELISAs, we demonstrate our assay's high specificity and quantitative capabilities using brain homogenates from tau transgenic mice, htau, JNPL3, and tau knockout. All 4 ELISAs show excellent specificity for mouse and human tau, with no reactivity to tau knockout animals. An age-dependent increase of serum tau in both tau transgenic models was also seen. Taken together, these assays are valuable methods to quantify tau and phospho-tau levels in transgenic animals, by examining tau levels in brain and measuring tau as a potential serum biomarker.
AB - Transgenic mouse models have been an invaluable resource in elucidating the complex roles of β-amyloid and tau in Alzheimer's disease. Although many laboratories rely on qualitative or semiquantitative techniques when investigating tau pathology, we have developed 4 Low-Tau, Sandwich enzyme-linked immunosorbent assays (ELISAs) that quantitatively assess different epitopes of tau relevant to Alzheimer's disease: total tau, pSer-202, pThr-231, and pSer-396/404. In this study, after comparing our assays with commercially available ELISAs, we demonstrate our assay's high specificity and quantitative capabilities using brain homogenates from tau transgenic mice, htau, JNPL3, and tau knockout. All 4 ELISAs show excellent specificity for mouse and human tau, with no reactivity to tau knockout animals. An age-dependent increase of serum tau in both tau transgenic models was also seen. Taken together, these assays are valuable methods to quantify tau and phospho-tau levels in transgenic animals, by examining tau levels in brain and measuring tau as a potential serum biomarker.
KW - Alzheimer's disease
KW - Htau
KW - JNPL3
KW - Sera
KW - Tau transgenic mice
KW - Tau-ELISA
UR - http://www.scopus.com/inward/record.url?scp=84868154722&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84868154722&partnerID=8YFLogxK
U2 - 10.1016/j.neurobiolaging.2012.05.010
DO - 10.1016/j.neurobiolaging.2012.05.010
M3 - Article
C2 - 22727277
AN - SCOPUS:84868154722
SN - 0197-4580
VL - 34
SP - 338
EP - 350
JO - Neurobiology of Aging
JF - Neurobiology of Aging
IS - 1
ER -